Le Lézard
Classified in: Ebola virus, Health
Subject: PDT

Clorox Healthcare Canada sets sights on helping to reduce hospital-borne infections and improve patient outcomes

TORONTO, Feb. 28, 2018 /CNW/ - Clorox Healthcare Canada's innovative array of disinfecting solutions are helping healthcare professionals in leading the fight against emerging hospital-borne infections, safeguarding patients in the places where they're most vulnerable.

Aging demographics and a spike in chronic conditions amongst Canadians combined with increased turnover of hospital rooms has forced healthcare providers to re-think their strategies for protecting patients at their most critical moments.

The threat is real. More than 200,000 patients get infections every year while receiving healthcare in Canada and more than 8,000 of these patients die as a result, according to a 2013 report from Canada's chief public health officer1.

To protect patients, hospitals have had to bolster their infection control teams and collaboration between infection prevention and environmental services as well as critical staff.

"There's been a greater effort to detect these bugs," explains Barley Chironda MSc, RPN, CIC Healthcare National Sales Director and Infection Control Specialist at Clorox Healthcare Canada. "What hospitals have realized is when there's a strong relationship between the infection prevention control and environmental services teams, then you actually have better compliance and reduced infection rates ? so that collaboration between those two stakeholders is significant."

To keep pace with the healthcare industry's evolving needs, Clorox Healthcare Canada has bolstered its own research surrounding microbiology, sporicidal agents and infection prevention. The result is a stream of innovative new products specifically for the hospital environment including Clorox Healthcare® Hydrogen Peroxide Cleaner Disinfectant Wipes, Clorox Healthcare® Bleach Germidical Wipes and Clorox Healthcare® Fusiontm Cleaner Disinfectant, a next-generation bleach product combining disinfecting efficacy against pathogens with broad surface compatibility.

The suite of ready-to-use facility-wide disinfectants for healthcare professionals tackle emerging pathogens like Clostridium difficile (C. difficile) spores, a bacterium causing serious illness in Canadian hospitals.

"One of the reasons C. difficile spreads so much is it creates that hard spore shell, making it extremely challenging to kill," says Chironda. "What we've been able to do at Clorox Healthcare is combine the technology of the bleach in the form of a wipe, making it a simple and efficient cleaning process."

Clorox Healthcare Canada offers a robust portfolio of surface cleaner-disinfectants, in addition to UV technology, to provide healthcare facilities with a comprehensive approach to environmental hygiene in efforts to prevent hospital-borne infections. Long trusted as a leader in disinfectant efficacy, Clorox Healthcare Canada also understands the challenges facilities face in balancing the need to prevent infections while protecting surfaces and costly equipment from damage.

Where sensitive surfaces require non-bleach solutions, Clorox Healthcaretm Hydrogen Peroxide Cleaner Disinfectant Wipes is a bleach alternative that kills 38 pathogens in one minute or less. The Clorox Healthcaretm Professional Disinfecting Bleach Wipes wipes provide broad-spectrum antimicrobial efficacy, able to combat 46 pathogens with kill times of one minute and effective against C. difficile spores in three minutes.

"C. difficile is the most critical pathogen facing healthcare, tomorrow it could be Ebola, the day after that it could be SARS, over the last couple of years we've had so many emerging threats," says Chironda. "For years Clorox Healthcare Canada has led the field with disinfectants that healthcare facilities trust for their broad efficacy, fast kill times and ease of use. So when emerging pathogens come through the doors, hospitals are even more prepared."

Visit www.cloroxprofessional.ca for more information.


1 https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/chief-public-health-officer-report-on-state-public-health-canada-2013-infectious-disease-never-ending-threat/healthcare-associated-infections-due-diligence.html (Accessed August 13, 2017)


SOURCE Clorox Healthcare Canada

These press releases may also interest you

at 08:00
Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular...

at 08:00
Benitec Biopharma Limited ("Benitec" or the "Company") (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW), a clinical-stage biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform combining RNA...

at 08:00
Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced its proprietary technology, "MuCTtm". This is a real-time PCR based data acquiring and analyzing technology that increases its multiplexing capability per...

at 08:00
Today, Bright Health announced plans to expand upon its Medicare Advantage product offerings with the addition of individual health plans in both Maricopa and Pima counties. Bright Health filed paperwork with the federal government to begin offering...

at 08:00
Murtaza "Mo" Khawaja is a young serial entrepreneur on the move. At just 21 years old, he and his brother launched Sparta Nutrition in 2016 and the company is already pulling in eight-figure annual revenue in just two years ? and steadily growing...

at 08:00
Tocagen Inc. , a clinical-stage, cancer-selective gene therapy company, today announced that it has completed the planned enrollment of 380 patients in the global Toca 5 pivotal Phase 3 trial approximately three months ahead of schedule. Toca 5 is a...

News published on 28 february 2018 at 06:00 and distributed by: